Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cardio Diagnostics's profit margin for the twelve months ending Dec 31, 2025 was -43832.5%. For fiscal 2025 it was -43832.5%, against -24028.2% the year before. The highest annual figure on record is -24028.2% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -43832.5% | −19804.3 |
| FY2024 | Dec 31, 2024 | -24028.2% | +25059.6 |
| FY2023 | Dec 31, 2023 | -49087.8% | +441542.2 |
| FY2022 | Dec 31, 2022 | -490630.0% | −421767.8 |
| FY2021 | Dec 31, 2021 | -68862.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -28012.5% | +5660.1 |
| Q1 FY2026 | Mar 31, 2026 | -66722.3% | −45254.7 |
| Q4 FY2025 | Dec 31, 2025 | -41219.9% | −24854.0 |
| Q1 FY2025 | Mar 31, 2025 | -173943.0% | −147802.9 |
| Q4 FY2024 | Dec 31, 2024 | -33672.6% | −7515.8 |
| Q3 FY2024 | Sep 30, 2024 | -21467.6% | −2201.5 |
| Q2 FY2024 | Jun 30, 2024 | -16365.9% | +216846.0 |
| Q1 FY2024 | Mar 31, 2024 | -26140.0% | – |
| Q4 FY2023 | Dec 31, 2023 | -26156.9% | – |
| Q3 FY2023 | Sep 30, 2023 | -19266.0% | – |
| Q2 FY2023 | Jun 30, 2023 | -233211.9% | – |